RBC Capital analyst Gregory Renza initiates coverage on Fulcrum Therapeutics (NASDAQ:FULC) with a Outperform rating and anno...

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.

U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday.

HC Wainwright & Co. analyst Andrew Fein maintains Fulcrum Therapeutics (NASDAQ:FULC) with a Buy and raises the price tar...

Piper Sandler analyst Edward Tenthoff maintains Fulcrum Therapeutics (NASDAQ:FULC) with a Overweight and raises the price ta...

Fulcrum Therapeutics (NASDAQ:FULC) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of ...

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...